$AIP

Hawkins Nicholas B. sold $301K of AIP

Hawkins Nicholas B. (VP and Chief Financial Officer) sold 10,631 shares of Arteris, Inc. (AIP) at an average of $28.28 ($28.26–$29.00, $0.30M total) across 2 trades over 2026-08-12 to 2026-08-13.

Original reporting
SEC EDGAR · Hawkins Nicholas B.
Published Aug 14, 2026, 8:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

Traders may treat the disclosure as a small sentiment input, but it does not change fundamentals because no guidance, earnings, or business development is included.

02

Market read

AIP saw a disclosed CFO open-market sale totaling about $300.6K across two trades, filed 2026-08-14.

03

What to watch

The article does not state tax, diversification, or compensation-related drivers, and it does not provide post-sale performance or any linkage to upcoming corporate events.

Relevance 4/10Novelty 5/10Timing: Filed on 2026-08-14 after-hours; reflects sales executed 2026-08-12 to 2026-08-13.

Background

The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Arteris CFO Nicholas Hawkins sold about $300.6K of AIP shares in open-market transactions dated 2026-08-12 to 2026-08-13.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction with a modest dollar value and no 10b5-1 plan indicated; however, insider sales are common and the article provides no new operational or financial catalyst.

Market effects

Minimal; this is company-specific insider activity with no sector-wide signal provided.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity management and does not necessarily signal reduced confidence, especially without evidence of any concurrent negative company news.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Nicholas B. Hawkins

    VP and Chief Financial Officer who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to